Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Clin Microbiol Infect Dis ; 39(1): 197-203, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31659566

RESUMEN

The actual role of Dientamoeba fragilis and Blastocystis in patients with gastrointestinal symptoms is still under debate. A multicenter case-control study was performed in The Netherlands to elucidate the clinical relevance of molecular diagnostics results in gastroenteritis (GE). Samples from this case-control study were used to perform a detailed analysis on the presence of D. fragilis and Blastocystis in relation to gastrointestinal symptoms. In the present study, a real-time PCR for Blastocystis was performed on 1374 case samples and 1026 control samples from the multicenter gastroenteritis case-control study previously tested for D. fragilis. Prevalence of both micro-organisms was highest in children under 20 years of age and lowest in the oldest age group. A significantly lower overall detection of D. fragilis and Blastocystis was found in cases (both 25.8%) as compared to controls (37.6% and 40.0%, respectively). The difference for D. fragilis was statistically significant for subjects above 20 years of age. For Blastocystis, the difference was statistically significant in all age groups, except in children less than 5 years of age. A negative relation between D. fragilis-positive cases and diarrhea was found in this study population. More GE symptoms were reported in cases without D. fragilis or Blastocystis. In the present study, prevalence of both D. fragilis and Blastocystis is lower in cases with gastroenteritic symptoms than in controls. Besides, in cases with D. fragilis or Blastocystis, no association is shown between any of the GE symptoms. Interestingly, this suggests that the presence of these protozoans may be considered characteristic of a healthy intestinal microbiome.


Asunto(s)
Infecciones por Blastocystis/epidemiología , Blastocystis/aislamiento & purificación , Dientamoeba/aislamiento & purificación , Dientamebiasis/epidemiología , Gastroenteritis/parasitología , Adolescente , Adulto , Estudios de Casos y Controles , Niño , Preescolar , Diarrea/parasitología , Heces/parasitología , Femenino , Gastroenteritis/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Prevalencia , Adulto Joven
2.
BMC Infect Dis ; 14: 27, 2014 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-24422880

RESUMEN

BACKGROUND: Resistance to carbapenem antibiotics is emerging worldwide among Enterobacteriaceae. To prevent hospital transmission due to unnoticed carriage of carbapenemase producing micro-organisms in newly admitted patients, or follow-up of patients in an outbreak setting, a molecular screening method was developed for detection of the most prevalent carbapenemase genes; blaOXA-48, blaVIM, blaIMP, blaNDM and blaKPC. METHODS: A real-time multiplex PCR assay was evaluated using a collection of 86 Gram negative isolates, including 62 carbapenemase producers. Seven different laboratories carried out this method and used the assay for detection of the carbapenemase genes on a selection of 20 isolates. RESULTS: Both sensitivity and specificity of the multiplex PCR assay was 100%, as established by results on the strain collection and the inter-laboratory comparisons. CONCLUSIONS: In this study, we present a multiplex real-time PCR that is a robust, reliable and rapid method for the detection of the most prevalent carbapenemases blaOXA-48, blaVIM, blaIMP, blaNDM and blaKPC, and is suitable for screening of broth cultured rectal swabs and for identification of carbapenemase genes in cultures.


Asunto(s)
Proteínas Bacterianas/genética , Carbapenémicos , Farmacorresistencia Bacteriana/genética , Enterobacteriaceae/genética , Reacción en Cadena de la Polimerasa Multiplex , beta-Lactamasas/genética , Humanos , Reacción en Cadena en Tiempo Real de la Polimerasa , Sensibilidad y Especificidad
3.
Clin Microbiol Rev ; 24(4): 701-17, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21976605

RESUMEN

Mycobacterium haemophilum is a slowly growing acid-fast bacillus (AFB) belonging to the group of nontuberculous mycobacteria (NTM) frequently found in environmental habitats, which can colonize and occasionally infect humans and animals. Several findings suggest that water reservoirs are a likely source of M. haemophilum infections. M. haemophilum causes mainly ulcerating skin infections and arthritis in persons who are severely immunocompromised. Disseminated and pulmonary infections occasionally occur. The second at-risk group is otherwise healthy children, who typically develop cervical and perihilar lymphadenitis. A full diagnostic regimen for the optimal detection of M. haemophilum includes acid-fast staining, culturing at two temperatures with iron-supplemented media, and molecular detection. The most preferable molecular assay is a real-time PCR targeting an M. haemophilum-specific internal transcribed spacer (ITS), but another approach is the application of a generic PCR for a mycobacterium-specific fragment with subsequent sequencing to identify M. haemophilum. No standard treatment guidelines are available, but published literature agrees that immunocompromised patients should be treated with multiple antibiotics, tailored to the disease presentation and underlying degree of immune suppression. The outcome of M. haemophilum cervicofacial lymphadenitis in immunocompetent patients favors surgical intervention rather than antibiotic treatment.


Asunto(s)
Infecciones por Mycobacterium/diagnóstico , Infecciones por Mycobacterium/terapia , Mycobacterium haemophilum/aislamiento & purificación , Animales , Humanos , Infecciones por Mycobacterium/microbiología , Mycobacterium haemophilum/genética
4.
PLoS One ; 16(11): e0258680, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34731182

RESUMEN

OBJECTIVE: To evaluate the pathogenicity of a broad range of 11 possible gastroenteritis viruses, by means of statistical relationships with cases vs. controls, or Ct-values, in order to establish the most appropriate diagnostic panel for our general practitioner (GP) patients in the Netherlands (2010-2012). METHODS: Archived stool samples from 1340 cases and 1100 controls were retested using internally controlled multiplex real-time PCRs for putative pathogenic gastroenteritis viruses: adenovirus, astrovirus, bocavirus, enterovirus, norovirus GI and GII, human parechovirus, rotavirus, salivirus, sapovirus, and torovirus. RESULTS: The prevalence of any virus in symptomatic cases and asymptomatic controls was 16.6% (223/1340) and 10.2% (112/1100), respectively. Prevalence of astrovirus (adjusted odds ratio (aOR) 10.37; 95% confidence interval (CI) 1.34-80.06) and norovirus GII (aOR 3.10; CI 1.62-5.92) was significantly higher in cases versus controls. Rotavirus was encountered only in cases. We did not find torovirus and there was no statistically significant relationship with cases for salivirus (aOR 1,67; (CI) 0.43-6.54)), adenovirus non-group F (aOR 1.20; CI 0.75-1.91), bocavirus (aOR 0.85; CI 0.05-13.64), enterovirus (aOR 0.83; CI 0.50-1.37), human parechovirus (aOR 1.61; CI 0.54-4.77) and sapovirus (aOR 1.15; CI 0.67-1.98). Though adenovirus group F (aOR 6.37; CI 0.80-50.92) and norovirus GI (aOR 2.22, CI: 0.79-6.23) are known enteropathogenic viruses and were more prevalent in cases than in controls, this did not reach significance in this study. The Ct value did not discriminate between carriage and disease in PCR-positive subjects. CONCLUSIONS: In our population, diagnostic gastroenteritis tests should screen for adenovirus group F, astrovirus, noroviruses GI and GII, and rotavirus. Case-control studies as ours are lacking and should also be carried out in populations from other epidemiological backgrounds.


Asunto(s)
Infecciones por Enterovirus/diagnóstico , Heces/virología , Gastroenteritis/diagnóstico , Adenoviridae/genética , Adenoviridae/aislamiento & purificación , Adenoviridae/patogenicidad , Bocavirus/genética , Bocavirus/aislamiento & purificación , Bocavirus/patogenicidad , Preescolar , Infecciones por Enterovirus/genética , Infecciones por Enterovirus/patología , Infecciones por Enterovirus/virología , Femenino , Gastroenteritis/genética , Gastroenteritis/patología , Gastroenteritis/virología , Médicos Generales , Humanos , Lactante , Masculino , Norovirus/genética , Norovirus/aislamiento & purificación , Norovirus/patogenicidad , Pacientes , Rotavirus/genética , Rotavirus/aislamiento & purificación , Rotavirus/patogenicidad , Sapovirus/genética , Sapovirus/aislamiento & purificación , Sapovirus/patogenicidad
5.
J Med Microbiol ; 67(9): 1348-1350, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30051803

RESUMEN

Mycoplasma amphoriforme is a species closely related to Mycoplasma pneumoniae, thus far with unknown clinical impact. The application of optimized diagnostics, better capable of differentiating between these two micro-organisms, identified a significant patient population positive for M. amphoriforme. The PCR designed by Ling et al. was used on respiratory samples that originally tested positive for M. pneumoniae (n=78), and identified 29 retrospectively as M. amphoriforme. The aim of this study is to describe and compare both groups. The group infected with M. amphoriforme was significantly older and more frequently had a co-infection (19 % vs 62 %), COPD and less fever. This could suggest that M. amphoriforme has opportunistic characteristics.


Asunto(s)
Infecciones por Mycoplasma/microbiología , Mycoplasma pneumoniae/aislamiento & purificación , Mycoplasma/aislamiento & purificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Hospitales , Humanos , Masculino , Persona de Mediana Edad , Mycoplasma/genética , Mycoplasma/fisiología , Mycoplasma pneumoniae/genética , Mycoplasma pneumoniae/fisiología , Países Bajos , Reacción en Cadena de la Polimerasa , Estudios Retrospectivos , Adulto Joven
6.
Clin Infect Dis ; 44(9): 1143-9, 2007 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-17407029

RESUMEN

BACKGROUND: An outbreak of Pneumocystis jiroveci pneumonia (PCP) occurred among renal transplant recipients attending the outpatient department at the Leiden University Medical Centre (Leiden, The Netherlands) from 1 March 2005 through 1 February 2006. Clinical, epidemiological, and molecular data were analyzed to trace the outbreak's origin. METHODS: Renal transplant recipients with a clinical suspected diagnosis of PCP were included in the study. The diagnosis had to be confirmed by direct microscopy or real-time polymerase chain reaction of the dihydropteroate synthase gene in a bronchoalveolar fluid specimen. To detect contacts between patients, a transmission map was constructed. A case-control analysis was performed to asses whether infection was associated with certain wardrooms. Genotyping of Pneumocystis isolates was performed by sequence analysis of the internal transcribed spacer (ITS) number 1 and 2 gene regions. RESULTS: Twenty-two confirmed PCP cases were identified; approximately 0-1 would have been expected over the same time period. No risk factor was predominantly present, and standard immunosuppressive regimens had not changed. Liver transplant recipients who used the same outpatient facilities had not acquired PCP. The transmission map findings were compatible with interhuman transmission on multiple occasions. The case-control study did not point to wardrooms as a common source. Genotyping by sequencing of the ITS1 and ITS2 gene regions revealed type Ne in 12 of 16 successfully typed samples. Genotype Ne was found in only 2 of 12 reference samples. CONCLUSIONS: The clinical data and genotyping results are compatible with either interhuman transmission or an environmental source of infection. More complex models may account for PCP clusters.


Asunto(s)
Infección Hospitalaria/transmisión , Brotes de Enfermedades , Trasplante de Riñón , Pneumocystis carinii/genética , Neumonía por Pneumocystis/epidemiología , Neumonía por Pneumocystis/transmisión , Anciano de 80 o más Años , Contaminación del Aire Interior/efectos adversos , Estudios de Casos y Controles , Femenino , Genotipo , Humanos , Masculino , Neumonía por Pneumocystis/virología
7.
Emerg Infect Dis ; 11(1): 62-8, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15705324

RESUMEN

Infections associated with Mycobacterium haemophilum are underdiagnosed because specific culture methods required for its recovery are not applied routinely. Using polymerase chain reaction (PCR) technology on fine needle aspirates and biopsied specimens from 89 children with cervicofacial lymphadenitis, we assessed the importance of M. haemophilum. Application of a Mycobacterium genus-specific real-time PCR in combination with amplicon sequencing and a M. haemophilum-specific PCR resulted in the recognition of M. haemophilum as the causative agent in 16 (18%) children with cervicofacial lymphadenitis. M. avium was the most frequently found species (56%), and M. haemophilum was the second most commonly recognized pathogen. Real-time PCR results were superior to culture because only 9 (56%) of the 16 diagnosed M. haemophilum infections were positive by culture.


Asunto(s)
Linfadenitis/diagnóstico , Infecciones por Mycobacterium/diagnóstico , Mycobacterium haemophilum/clasificación , Mycobacterium haemophilum/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Biopsia , Biopsia con Aguja , Niño , Humanos , Linfadenitis/microbiología , Infecciones por Mycobacterium/microbiología , Mycobacterium haemophilum/genética , Sensibilidad y Especificidad , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA